|

Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?

RECRUITINGSponsored by York University
Actively Recruiting
SponsorYork University
Started2026-06-01
Est. completion2027-06-30
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted

Summary

Millions have developed Long COVID (LC), and recent findings show an association between taurine deficiency (an amino acid) and symptoms in LC. Cost-effective and accessible interventions are needed to improve welfare and reduce healthcare costs. We will investigate the efficacy of 12-weeks of taurine supplementation (self-administered), on vascular function and the cardio/cerebrovascular responses to upright posture. We will measure resting vascular function with an EndoPAT device, resting heart rate variability, and the blood pressure, heart rate, and brain blood flow responses to 5 minutes of head-up tilt before and after weeks of taurine supplementation in LC. We hypothesize that the 12 weeks of supplementation will improve both resting vascular function and the responses to upright tilt. In turn, we hypothesize that symptoms will also improve (as measured by questionnaires).

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Participants will have had symptoms of Long COVID post-infection for at least 3 months

Exclusion Criteria:

* Inability to undergo tilt table testing for 5 minutes
* Inability to transport selves to York University from their homes
* Inability to speak English, or provide a translator
* Blood clotting disorders

Conditions2

Heart DiseaseLong COVID Syndrome

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.